Protective Effects of Nigella sativa Oil in Hyperoxia-Induced Lung Injury;Efectos protectores del aceite de Nigella sativa en la lesión pulmonar inducida por hiperoxia

Archivos de Bronconeumologia

Volumn 49, Issue 1, 2013, Pages 15-21

  Tayman, Cuneyt ^a   Cekmez, Ferhat ^a   Kafa, Ilker Mustafa ^b   Canpolat, Fuat Emre ^a   Cetinkaya, Merih ^a   Tonbul, Alparslan ^c   Uysal, Sema ^c   Tunc, Turan ^a   Sarici, S Umit ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b ULUDAG UNIVERSITY   (Turkey)

^c FATIH UNIVERSITY   (Turkey)

Author keywords

Aceite de Nigella sativa; Bronchopulmonary dysplasia; Displasia broncopulmonar; Lesi n pulmonar inducida por ox geno; Nigella sativa oil; Oxygen induced lung injury; Preterm infants; Protecci n; Protection; Rat; Rata; Reci n nacidos pret rmino

Indexed keywords

GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYELOPEROXIDASE; NIGELLA SATIVA OIL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMICAL COMPOSITION; BLACK CUMIN; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; HISTOPATHOLOGY; HYPEROXIA; IMMUNOCHEMISTRY; LUNG INJURY; NEWBORN; NONHUMAN; RAT;

EID: 84871720352     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2012.11.003     Document Type: Article

References (40)

1. Kinsella J.P., Greenough A., Abman S.H. Bronchopulmonary dysplasia. Lancet 2006, 367:1421-1431.
2. Philip A.G.S. Chronic lung disease of prematurity: A short history. Semin Fetal Neonatal Med 2009, 14:333-338.
3. Greenough A. Prenatal factors in the development of chronic lung disease. Semin Fetal Neonatal Med 2009, 14:339-344.
4. Van Marter L.J. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009, 14:358-366.
5. Northway W.H., Rosan R.C., Porter D.Y. Pulmonary disease following respirator therapy of hyaline-membrane disease: bronchopulmonary dysplasia. N Engl J Med 1967, 276:357-368.
6. Davis P.G., Thorpe K., Roberts R., Schmidth B., Doyle L.W., Kirpalani H., et al. Evaluating old definitions for the new bronchopulmonary dysplasia. J Pediatr 2002, 140:555-560.
7. Laughon M.M., Smith P.B., Bose C. Prevention of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 2009, 14:374-382.
8. Ali B.H., Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2003, 17:299-305.
9. Boskabady M.H., Mohsenpoor N., Takaloo L. Antiasthmatic effects of Nigella sativa in airway of asthmatic patients. Phytomedicine 2010, 17:707-713.
10. Boskabady M.H., Farhadi J. The possible prophylactic effect of Nigella sativa seed aqueous extract on respiratory symptoms and pulmonary function tests on chemical war victims: a randomized, double-blind, placebo-controlled trial. J Altern Complemen Med 2008, 14:1137-1144.
11. Boskabady M.H., Nasim V., Sediqa A. The protective effect of Nigella sativa on lung injury of sulfur mustard-exposed guinea pigs. Exp Lung Res 2008, 34:183-194.
12. Kanter M. Effects of Nigella sativa seed extract on ameliorating lung tissue damage in rats after experimental pulmonary aspirations. Acta Histochem 2009, 111:393-403.
13. el Tahir K.E., Ashour M.M., al-Harbi M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen Pharmacol 1993, 24:1123-1131.
14. Abdel-Wahhab M.A., Aly S.E. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol 2005, 25:218-223.
15. Kacem R., Meraihi Z. Effects of essential oil extracted from Nigella sativa (L.) seeds and its main components on human neutrophil elastase activitiy. Yakugaku Zasshi 2006, 126:301-305.
16. Salem M.L. Immunomodulatory and therapeutic properties of the Nigella sativa L. seed. Int Immunopharmacol 2005, 5:1749-1770.
17. Raza Asim M.B., Shahzad M., Yang X., Sun Q., Zhang F., Han Y., et al. Suppressive effects of black seed oil on ovalbumin induced acute lung remodelling in E3 rats. Swiss Med Wkly 2010, 140:w13128. 10.4414/smw.2010.13128.
18. Askenazi S.S., Perlman M. Pulmonary hypoplasia: lung weight and radial alveolar count as criteria of diagnosis. Arch Dis Child 1979, 54:614-618.
19. Tsuchiya T., Nishimura Y., Nishiuma T., Kotani Y., Funada Y., Yoshimura S., et al. Airway remodeling of murine chronic antigen exposure model. J Asthma 2003, 40:935-944.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
21. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988, 34:497-500.
22. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967, 70:158-169.
23. Draper H.H., Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-431.
24. Tihan D.N., Erbil Y., Seven R., Arkaya S., Türkoĝlu U., Hepgül G., et al. The effect of glutamine on oxidative damage in an experimental abdominal compartment syndrome model in rats. Ulus Travma Acil Cerrahi Derg 2011, 17:1-8.
25. Merritt T.A., Deming D.D., Boynton B.R. The 'new' bronchopulmonary dysplasia: challenges and commentary. Semin Fetal Neonatal Med 2009, 14:345-357.
26. Lee J.W., Davis J.M. Future applications of antioxidants in premature infants. Curr Opin Pediatr 2011, 23:161-166.
27. Northway W.H. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 1992, 89:969-973.
28. Albertine K.H., Plopper C.G. DNA oxidation or apoptosis: will the real culprit of DNA damage in hyperoxic lung injury please stand up. Am J Respir Cell Mol Biol 2002, 26:381-383.
29. Rogers S., Witz G., Anwar M., Hiatt M., Hegy T. Antioxidant capacity and oxygen radical diseases in the preterm newborn. Arch Pediatr Adolesc Med 2000, 154:544-548.
30. Bayrak O., Bavbek N., Karatas O.F., Bayrak R., Catal F., Cimentepe E., et al. Nigella sativa protects against ischaemia/reperfusion injury in rat kidneys. Nephrol Dial Transplant 2008, 23:2206-2212.
31. Ebru U., Burak U., Yusuf S., Reyhan B., Arif K., Faruk T.H., et al. Cardioprotective effects of Nigella sativa oil on cyclosporine A-induced cardiotoxicity in rats. Basic Clin Pharmacol Toxicol 2008, 103:574-580.
32. Romero F.J., Bosch-Morell F., Romero M.J., Jareño E.J., Romero B., Marín N., et al. Lipid peroxidation products and antioxidants in human disease. Environ Health Perspect 1998, 106:1229-1234.
33. Butt M.S., Sultan M.T. Nigella sativa: reduces the risk of various maladies. Crit Rev Food Sci Nutr 2010, 50:654-665.
34. Merritt T.A., Cochrane C.G., Holcomb K., Bohl B., Hallman M., Strayer D., et al. Elastase and alpha 1-proteinase inhibitor activity in tracheal aspirates during respiratory distress syndrome. Role of inflammation in the pathogenesis of bronchopulmonary dysplasia. J Clin Invest 1983, 72:656-666.
35. Yi M., Jankov R.P., Belcastro R., Humes D., Copland I., Shek S., et al. Opposing effects of 60% oxygen and neutrophil influx on alveologenesis in the neonatal rat. Am J Respir Crit Care 2004, 170:1188-1196.
36. Kettle A.J., Winterbourn C.C. Myeloperoxidase: a key regulator of neutrophil oxidant production. Redox Rep 1997, 3:3-15.
37. Lee J.H., Sung D.K., Koo S.H., Shin B.K., Hong Y.S., Son C.S., et al. Erythropoietin attenuates hyperoxia-induced lung injury by down-modulating inflammation in neonatal rats. J Korean Med Sci 2007, 22:1042-1047.
38. Wang Y., Santos J., Sakurai R., Shin E., Cerny L., Torday J.S., et al. Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res 2009, 65:150-155.
39. Ozer E.A., Kumral A., Ozer E., Duman N., Yilmaz O., Ozkal S., et al. Effect of retinoic acid on oxygen-induced lung injury in the newborn rat. Pediatr Pulmonol 2005, 39:35-40.
40. Dasgupta C., Sakurai R., Wang Y., Guo P., Ambalavanan N., Torday J.S., et al. Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 2009, 296:L1031-L1041.